Blood Type Predisposes to Certain Viral Infections
|
By LabMedica International staff writers Posted on 30 Apr 2012 |
Some strains of Rotavirus find their way into the cells of the gastrointestinal tract by recognizing antigens associated with the type A blood group.
Histo-blood group antigens are known to promote binding of Norovirus and Helicobacter pylori cells to intestinal cells, but this had never been demonstrated in Rotavirus, a major intestinal pathogen that is the leading cause of severe dehydration and diarrhea in infants around the world.
Scientists at Baylor College of Medicine (Houston, TX, USA) examined the structure of a key part of a strain of the virus known as P[14] which provides a clue to how the virus infects human cells. The scientists used various techniques including protein expression and purification, crystallization, glycan array screening, inhibition and infectivity assays, and hemagglutination assays.
In strains of Rotavirus that infect animals, the top of a spike on the virus attaches to the cell via a glycan, one of many sugars linked together to form complex branched-chain structures with a terminal molecule of sialic acid. The same did not appear to be true of virus strains that infect humans, and scientists believed the human Rotavirus strains were bound to glycans with an internal sialic acid molecule, but they did not know how this occurs.
The investigators determined the structure of the top of the virus spike domain, known as VP8*, and found that the type A glycan bound to the Rotavirus spike protein at the same place as the sialic acid would have in an animal Rotavirus. They used crystallography, to show subtle changes in the structure of the VP8* domain of the virus that allowed it to use the histo-blood group antigen A as a receptor. An antibody to the histo-blood group antigen A blocked infection by the virus into human intestinal cells in culture. The authors found humans infected with the P[14] strain had type A blood, but more studies are needed to confirm the connection.
B. V. Venkataram Prasad, PhD, the lead author and professor of biochemistry and molecular biology at Baylor College of Medicine, said, "We wondered how this genotype of Rotavirus recognized a cellular glycan. We did a glycan array analysis to see which glycans interacted with the top of the virus spike, called VP8*. No one expected this. Is there an emerging theme here with these intestinal pathogens? Do other viruses use these blood group antigens as a door to enter the cell? The question now is do different strains use other histo-blood group antigens in this way?" Further studies identified a second Rotavirus strain P[9] that uses the histo-blood group antigen as a receptor. The study was published online on April 15 2012 in the journal Nature.
Related Links:
Baylor College of Medicine
Histo-blood group antigens are known to promote binding of Norovirus and Helicobacter pylori cells to intestinal cells, but this had never been demonstrated in Rotavirus, a major intestinal pathogen that is the leading cause of severe dehydration and diarrhea in infants around the world.
Scientists at Baylor College of Medicine (Houston, TX, USA) examined the structure of a key part of a strain of the virus known as P[14] which provides a clue to how the virus infects human cells. The scientists used various techniques including protein expression and purification, crystallization, glycan array screening, inhibition and infectivity assays, and hemagglutination assays.
In strains of Rotavirus that infect animals, the top of a spike on the virus attaches to the cell via a glycan, one of many sugars linked together to form complex branched-chain structures with a terminal molecule of sialic acid. The same did not appear to be true of virus strains that infect humans, and scientists believed the human Rotavirus strains were bound to glycans with an internal sialic acid molecule, but they did not know how this occurs.
The investigators determined the structure of the top of the virus spike domain, known as VP8*, and found that the type A glycan bound to the Rotavirus spike protein at the same place as the sialic acid would have in an animal Rotavirus. They used crystallography, to show subtle changes in the structure of the VP8* domain of the virus that allowed it to use the histo-blood group antigen A as a receptor. An antibody to the histo-blood group antigen A blocked infection by the virus into human intestinal cells in culture. The authors found humans infected with the P[14] strain had type A blood, but more studies are needed to confirm the connection.
B. V. Venkataram Prasad, PhD, the lead author and professor of biochemistry and molecular biology at Baylor College of Medicine, said, "We wondered how this genotype of Rotavirus recognized a cellular glycan. We did a glycan array analysis to see which glycans interacted with the top of the virus spike, called VP8*. No one expected this. Is there an emerging theme here with these intestinal pathogens? Do other viruses use these blood group antigens as a door to enter the cell? The question now is do different strains use other histo-blood group antigens in this way?" Further studies identified a second Rotavirus strain P[9] that uses the histo-blood group antigen as a receptor. The study was published online on April 15 2012 in the journal Nature.
Related Links:
Baylor College of Medicine
Latest Clinical Chem. News
- Saliva-Based Test Detects Biochemical Signs of Sleep Loss
- Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
- Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
- Urine-Based Test Shows Promise for Autism Screening in Children
- Blood-Based Sensor Detects Early Signs of Alzheimer’s and Parkinson’s
- Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis
- Urine-Based Alzheimer’s Test Receives FDA Breakthrough Device Designation
- Fluid Biomarker Improves Diagnosis and Monitoring of Primary CNS Lymphoma
- New CA19-9 Cutoff Value Helps Identify High-Risk Pancreatic Cancer Patients
- Blood-Based Biomarkers Show Promise for Psychosis Risk Prediction
- International Experts Recommend Ending Routine 'Corrected' Calcium Reporting
- Long-Term Data Show PSA Screening Modestly Reduces Prostate Cancer Deaths
- Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively
- FDA-Cleared Assay Enables Comprehensive Automated Testosterone Testing
- CE-Marked Blood Biomarker Test Advances Automated Alzheimer’s Diagnostics
- Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection
Channels
Molecular Diagnostics
view channel
Blood Test Predicts Immunotherapy Response in Head and Neck Cancer
Head and neck squamous cell carcinoma affects hundreds of thousands of people worldwide each year, yet response rates to immunotherapy remain low. Clinicians lack reliable, minimally invasive tools to... Read more
New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance
Rapid identification of Ebola infections is essential to limit transmission and guide public health response, yet detection can be difficult when outbreaks involve rare variants. The current outbreaks... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read morePathology
view channel
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more








